[Cerebrolysin in the treatment of brain injuries of moderate severity].

Talypov AE, Myachin MY, Kuksova NS, Kordonsky AY

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova1 Jan 2014

PMID25591645PepBankPUB-25591645

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study7

7 results from studies that gave the peptide. 7 results from people.

01HumanNon-randomized trialEfficacy outcome
In moderate brain injury patients, Cerebrolysin promoted early and complete reduction of common symptoms.
In plain wordsIn moderate brain injury patients, Cerebrolysin reduced common symptoms compared with matched patients.
Peptide
Cerebrolysin
Outcome
DecreaseCommon brain injury symptoms
Study
n = 62
Comparator
Patients matched for age, sex and disease severity
Outcome group
Neuroprotection · Nervous system and cognition
Studied dose
Dose not stated
Source sentences
Summary
Cerebrolysin promoted the early and complete reduction of common symptoms of brain injury as well as autonomic and asthenic disorders, restoration of cognitive functions, normalization of emotional condition, improvement of spontaneous bioelectrical activity.
1 context sentence(design, population, supporting numbers)
Summary · context
The main group included 30 patients treated with cerebrolysin from the first day of disease, the comparison group included 32 patients matched for age, sex and disease severity.
Report a problemFND-2559164501
02HumanNon-randomized trialEfficacy outcome
In moderate brain injury patients, Cerebrolysin promoted reduction of autonomic disorders.
In plain wordsIn moderate brain injury patients, Cerebrolysin reduced autonomic disorders compared with matched patients.
Peptide
Cerebrolysin
Outcome
DecreaseAutonomic disorders
Study
n = 62
Comparator
Patients matched for age, sex and disease severity
Outcome group
Neuroprotection · Nervous system and cognition
Studied dose
Dose not stated
Source sentences
Summary
Cerebrolysin promoted the early and complete reduction of common symptoms of brain injury as well as autonomic and asthenic disorders, restoration of cognitive functions, normalization of emotional condition, improvement of spontaneous bioelectrical activity.
1 context sentence(design, population, supporting numbers)
Summary · context
The main group included 30 patients treated with cerebrolysin from the first day of disease, the comparison group included 32 patients matched for age, sex and disease severity.
Report a problemFND-2559164502
03HumanNon-randomized trialEfficacy outcome
In moderate brain injury patients, Cerebrolysin promoted reduction of asthenic disorders.
In plain wordsIn moderate brain injury patients, Cerebrolysin reduced weakness-related disorders compared with matched patients.
Peptide
Cerebrolysin
Outcome
DecreaseAsthenic disorders
Study
n = 62
Comparator
Patients matched for age, sex and disease severity
Outcome group
Exercise and physical function · Whole body
Studied dose
Dose not stated
Source sentences
Summary
Cerebrolysin promoted the early and complete reduction of common symptoms of brain injury as well as autonomic and asthenic disorders, restoration of cognitive functions, normalization of emotional condition, improvement of spontaneous bioelectrical activity.
1 context sentence(design, population, supporting numbers)
Summary · context
The main group included 30 patients treated with cerebrolysin from the first day of disease, the comparison group included 32 patients matched for age, sex and disease severity.
Report a problemFND-2559164503
04HumanNon-randomized trialEfficacy outcome
In moderate brain injury patients, Cerebrolysin promoted restoration of cognitive functions.
In plain wordsIn moderate brain injury patients, Cerebrolysin restored thinking abilities compared with matched patients.
Peptide
Cerebrolysin
Outcome
Not applicableCognitive functions
Study
n = 62
Comparator
Patients matched for age, sex and disease severity
Outcome group
Cognition and memory · Nervous system and cognition
Studied dose
Dose not stated
Source sentences
Summary
Cerebrolysin promoted the early and complete reduction of common symptoms of brain injury as well as autonomic and asthenic disorders, restoration of cognitive functions, normalization of emotional condition, improvement of spontaneous bioelectrical activity.
1 context sentence(design, population, supporting numbers)
Summary · context
The main group included 30 patients treated with cerebrolysin from the first day of disease, the comparison group included 32 patients matched for age, sex and disease severity.
Report a problemFND-2559164504
05HumanNon-randomized trialEfficacy outcome
In moderate brain injury patients, Cerebrolysin promoted normalization of emotional condition.
In plain wordsIn moderate brain injury patients, Cerebrolysin normalized emotional condition compared with matched patients.
Peptide
Cerebrolysin
Outcome
Not applicableEmotional condition
Study
n = 62
Comparator
Patients matched for age, sex and disease severity
Outcome group
Anxiety and mood · Mental health and mood
Studied dose
Dose not stated
Source sentences
Summary
Cerebrolysin promoted the early and complete reduction of common symptoms of brain injury as well as autonomic and asthenic disorders, restoration of cognitive functions, normalization of emotional condition, improvement of spontaneous bioelectrical activity.
1 context sentence(design, population, supporting numbers)
Summary · context
The main group included 30 patients treated with cerebrolysin from the first day of disease, the comparison group included 32 patients matched for age, sex and disease severity.
Report a problemFND-2559164505
06HumanNon-randomized trialEfficacy outcome
In moderate brain injury patients, Cerebrolysin improved spontaneous bioelectrical activity.
In plain wordsIn moderate brain injury patients, Cerebrolysin improved spontaneous brain electrical activity compared with matched patients.
Peptide
Cerebrolysin
Outcome
Not applicableSpontaneous bioelectrical activity
Study
n = 62
Comparator
Patients matched for age, sex and disease severity
Outcome group
Neuroprotection · Nervous system and cognition
Studied dose
Dose not stated
Source sentences
Summary
Cerebrolysin promoted the early and complete reduction of common symptoms of brain injury as well as autonomic and asthenic disorders, restoration of cognitive functions, normalization of emotional condition, improvement of spontaneous bioelectrical activity.
1 context sentence(design, population, supporting numbers)
Summary · context
The main group included 30 patients treated with cerebrolysin from the first day of disease, the comparison group included 32 patients matched for age, sex and disease severity.
Report a problemFND-2559164506
07HumanNon-randomized trialSafety outcome
In moderate brain injury patients, Cerebrolysin was well tolerated.
In plain wordsIn moderate brain injury patients, Cerebrolysin was well tolerated.
Peptide
Cerebrolysin
Outcome
Not applicableTolerability
Study
n = 30
Outcome group
Adverse events · Whole body
Studied dose
Dose not stated
Source sentences
Summary
The drug was well-tolerated.
1 context sentence(design, population, supporting numbers)
Summary · context
The main group included 30 patients treated with cerebrolysin from the first day of disease, the comparison group included 32 patients matched for age, sex and disease severity.
Report a problemFND-2559164507

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

Version 2Current
14 Oct 2026, 05:02 UTC
Study results updated
Version 1
14 Oct 2026, 01:46 UTC
First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

MeSH terms

PepBank is a research reference. Talk to a doctor before you use any peptide.